Beijing Mabworks Biotech Co., Ltd. announced a private placement of 2,095,558 common shares at a price of CNY 71.58 for gross proceeds of CNY 150,000,041.64 on August 1, 2023. The transaction will include participation from new investor, received CNY Betta Pharmaceuticals Co., Ltd. for 2.91% stake. The transaction has been approved by the 6th session of the company?s 4th directorate and the 4th session of the company?s 4th supervisory board.